ecrin-mdr-crcClinical2020Metastatic Colorectal CancerMetastatic Colorectal CancerInterventionalhttps://newmdr.ecrin.org/Study/2693053China4ECRIN MDRRecruitingfalseA Phase I/II Study of Irinotecan, Oxaliplatin, Capecitabine (XELOXIRI) and Bevacizumab as a First-Line Therapy for Patients with Metastatic Colorectal CancerInterventions: experimental group:XELOXIRI/bevacizumab Primary outcome(s): DLT;MTD;RP2D;ORR Study Design: Single arm2020-04-152693053ChiCTR2000032590